Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study
BackgroundAlthough a recent study reported that fibrates are associated with a low risk of cardiovascular (CV) death and can postpone the need for long-term hemodialysis in patients with advanced chronic kidney disease (CKD), little is known regarding whether the CV protective effects of fibrates ex...
Κύριοι συγγραφείς: | Wen-Yu Ho, Chieh-Li Yen, Cheng-Chia Lee, Yi-Ran Tu, Chao-Yu Chen, Ching-Chung Hsiao, Pao-Hsien Chu, Hsiang-Hao Hsu, Ya-Chun Tian, Chih-Hsiang Chang |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Frontiers Media S.A.
2022-11-01
|
Σειρά: | Frontiers in Cardiovascular Medicine |
Θέματα: | |
Διαθέσιμο Online: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.907539/full |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Fibrate and the risk of cardiovascular disease among moderate chronic kidney disease patients with primary hypertriglyceridemia
ανά: Chieh-Li Yen, κ.ά.
Έκδοση: (2024-02-01) -
Clifford Fibrations and Possible Kinematics
ανά: Alan S. McRae
Έκδοση: (2009-07-01) -
Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease
ανά: Chieh‐Li Yen, κ.ά.
Έκδοση: (2022-10-01) -
Chemical degradation kinetics of fibrates: bezafibrate, ciprofibrate and fenofibrate
ανά: Marcelo Antonio de Oliveira, κ.ά. -
Digital <i>h</i>-Fibrations and Some New Results on Digital Fibrations
ανά: Talip Can Termen, κ.ά.
Έκδοση: (2024-03-01)